Contaminated Blood and Blood Products

Owen Smith Excerpts

Thursday 14th October 2010 Commons Chamber

[Owen Smith (Pontypridd) (Lab)]

First, I join other right hon. and hon. Members in thanking the Backbench Business Committee for recognising the importance of the case that my hon. Friend the Member for Coventry North West (Mr Robinson) and I put to it. The volume and the quality of the contributions we have heard today bear eloquent testimony to the fact that the Business Committee was absolutely right to note that this is a critical issue—one that many hon. Members on both sides of the House feel has received too little attention in recent years from successive Governments. I also thank my hon. Friend the Member for Coventry North West for picking up the baton and moving the motion, which he did with great aplomb and verve, as ever.

Most of all, I should like to thank the victims and their families who have been in contact with me since we first learned that we had succeeded in securing this debate. Their kind words and support have been hugely welcome. I am delighted that so many of them managed to come here today—and, indeed, yesterday—to witness the debate. That bears extraordinarily powerful testament to the wrong that has been done to them and their families. I hope that we are doing some justice to their cases today by debating this issue so fully.

I am extremely pleased that the debate has prompted the Government to put before the House today’s statement, which is somewhat misaligned with the wrecking amendment, as my hon. Friend described it.

[Mr Robinson]

I wonder, Madam Deputy Speaker, whether you could put the point to the Minister that we are conducting the debate on the basis of the ministerial statement that has been placed in the Library rather than one made to the House. Perhaps the Minister can tell us what the basis of compensation would be if we were to implement the Archer recommendations. Is the figure £3 billion, £300 million or £1.2 billion? I have heard different figures. Does my hon. Friend agree that we cannot continue the debate without more clarity about what we are considering? The Government have stated that we are inviting them to spend £3 billion, but the figure might in fact be far less.

[Owen Smith]

I, too, would very much like that point to be addressed. I was going to ask the Minister how the £3 billion figure was calculated. The Haemophilia Society has today suggested that the figure has been calculated erroneously on the basis of a typographical error in the Archer report and that the number has been extrapolated from a false figure that Archer published regarding the volumes that were given in Ireland. So, I, too, would welcome the Minister’s clarification on that hugely important point.

[Mr Dorrell]

I entirely agree with the hon. Gentleman and other hon. Members that the number of pounds we are talking about is, to put it mildly, salient. However, is it not also relevant that the House is being asked to sign up not to a specific sum but to the principle that the compensation payable in this country should be at least aligned with that payable in the Republic of Ireland? Whatever the number, the House should not sign up to the dubious principle that whatever is paid in Ireland we will pay here.

--- Later in debate ---

[Owen Smith]

I understand the right hon. Gentleman’s argument, which is a good one intellectually, but the rationale for the recommendation’s inclusion in the motion was, essentially, that the victims of this tragedy wanted the House to debate it. The Archer report is the only substantive inquiry that we have had. It came to that conclusion on compensation, so we felt it appropriate to ask that question of the House. However, I understand the right hon. Gentleman’s point about tying ourselves to recommendations that are made in another jurisdiction.

[Alun Cairns (Vale of Glamorgan) (Con)]

I pay tribute to the hon. Gentleman for pressing for the motion today. I am obviously keen to support him. On the debate about parity with the Republic of Ireland, the Minister in her statement talked about working with the UK’s devolved Administrations and with their Health Ministers. Does the hon. Gentleman also support the need for parity within the UK? Will he urge the Minister before us and the Minister in Wales, because we are both Welsh Members, to work on the review with the Department of Health in order to come up with at least some parity within the UK?

[Mr Deputy Speaker (Mr Lindsay Hoyle)]

Order. It is up to Members to decide on the number of times that they give way to interventions, but I am concerned that that is going to stop other Members getting in. If we are going to have interventions, Mr Cairns, we need to make them very brief.

[Owen Smith]

I agree with the hon. Gentleman’s excellent point. One thing that I was slightly disappointed about in the ministerial statement was the fact that those discussions clearly have not taken place. Some of the statement’s specifics are very welcome, particularly its point about the terms of reference and, notably, the fact that the level of payment to people with hepatitis C might be equalised.

[Ms Abbott]

On a point of order, Mr Deputy Speaker. You will be aware that “Mr Secretary Lansley” and “Anne Milton” tabled an amendment that is on the Order Paper and includes the figure “£3 billion”. Some Opposition Members feel that this debate cannot go forward until we have some clarification of its accuracy.

[Mr Deputy Speaker]

A point of order takes up valuable time, too. I recognise that you wanted to make it, but you will have the opportunity to put the case a little later. What we ought to try to do is respect all Members. I want to try to get in all those Members who are here; I do not want disappoint them.

[Owen Smith]

Thank you, Mr Deputy Speaker. I now have very little time left, so I shall speak a little faster, if I may.

It is absolutely critical that the Minister makes it very clear in her response that she is talking about equalising the payment to people with hepatitis C with the previous payments to victims of HIV. It is also important that she consider the specificity of the recommendations, including the terms of reference. Victims’ access to nursing care and to the NHS ought to be looked at differentially. They were infected by the NHS, in effect, and therefore they ought to be treated differently when looked after by the NHS.

In the last minute of my speech, I want to pay tribute to some people in the Public Gallery today. The reason I am so interested in today’s debate is that a very brave constituent of mine, Leigh Sugar, died earlier this year. His family came to see me just days after his death to express their desire for him to be the last person who suffers in their dying days, having not been looked after properly by the NHS, and having been infected through NHS treatment.

Leigh is a classic example of a person who, as a mild haemophiliac, went to hospital—he, in his teens—to be treated for the condition and came out with a devastating disease. That disease ultimately led to his death from liver cancer. Far too many people have died before we have seen this House deliver justice, and it is absolutely critical that justice be seen to be done today. This is a moral issue, it is a matter of conscience and of justice, and we owe it to the victims, whatever the difficulties of the CSR, to see justice served so that they might be properly recognised and properly recompensed.